products enterodiol and enterolactone have weak estrogenic activity, but they may also exert biological effects through non-estrogenic means.

A 2021 review found that lignans have a positive effect on lipid profiles of patients with dyslipidemia related diseases. as of 2022, there is limited evidence that dietary intake of lignans is associated with a reduced cancer and cardiovascular disease